RISE Global Obesity Industry TOP2+ (476310)
NAV
10,328KRW
-10.59하락 (-0.1%)
Market Price per share (KRW)
10,230KRW
-85하락 (-0.82%)
※ t-1 last price
trading volume
1,755shares
AUM
KRW 8.2billion
KEY POINT
Focus on investing in key corporations of the global megatrend in obesity treatment.
KEY POINT
It allocates 28% each to the market's First Mover, Eli Lilly (LLY) and Novo Nordisk (NVO), while the rest is invested in global pharmaceutical and fitness-related companies.
ETF Name (code) | Benchmark Index | Inception date | Creation Unit | AUM (KRW) |
---|---|---|---|---|
KB RISE Global Obesity Care Industry TOP2+ ETF
(476310) |
KEDI Global Obesity Care Industry Top2+ Index | 2024.02.27 | 50,000 | 8,262,146,822 |
Trustee | Market Price per share (KRW) | NAV | Trading Volume (shares) | |
한국씨티은행 |
10,230
※ t-1 last price |
10,327 | 1,755 |
ETF Name(Code) | Benchmark Index |
---|---|
KB RISE Global Obesity Care Industry TOP2+ ETF (476310) |
KEDI Global Obesity Care Industry Top2+ Index |
Inception date | Creation Unit |
2024.02.27 | 50,000 |
AUM(0.1 billion) (KRW) | Trustee |
8,262,146,822 | 한국씨티은행 |
Market Price per share (KRW) | iNAV per share (KRW) |
10,230
※ t-1 last price |
10,327 |
Trading Volume (shares) | |
1,755 |
Index Introduction
The KEDI Global Obesity Industry Top2+ Index is comprised of companies in the obesity industry, a global megatrend. It allocates 28% of its composition to Eli Lilly (LLY) and Novo Nordisk (NVO), the first movers in the obesity treatment market, and the remainder to global pharmaceutical companies and fitness-related enterprises, utilizing a market capitalization-weighted method.
TOP 10 Holdings
Rank | Name | Weight (%) |
---|---|---|
1 | ELI LILLY & CO | 27.77 |
2 | NOVO NORDISK AS SPONS ADR | 27.65 |
3 | MERCK & CO.INC | 10.07 |
4 | ASTRAZENECA PLC SPONS ADR | 9.10 |
5 | NORVARTIS AG ADR | 7.40 |
6 | ABBOTT LABORATORIES | 5.27 |
7 | AMGEN INC | 3.19 |
8 | PLANET FITNESS INC CL A | 3.01 |
9 | DICKS SPORTING GOODS INC | 2.94 |
10 | LULULEMON ATHLETICA INC | 2.92 |
proportion by sectors
*The proportion of investment stocks
Rank | Name | Weight (%) |
---|---|---|
1 | Health Care | 63.44 |
2 | Etc | 33.61 |
3 | Consumer Discretionary | 2.94 |
- Investment notice
- - The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- - Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- - Past performance does not guarantee future profits.
- - In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- - Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- - Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.